Skip to main content
. Author manuscript; available in PMC: 2015 May 4.
Published in final edited form as: Subst Use Misuse. 2014 Oct 7;50(1):40–52. doi: 10.3109/10826084.2014.957771

TABLE 2.

Clinical characteristics of AUD at two timepoints: Scan 1 (before treatment) and Scan 2 (5–7 days after initiation of lorazepam/disulfiram combination)

Scan 1
 Scan 2
Mean SD Mean SD p Value Cohen’s da
Anxiety Likert pre Stroopb 3.00 1.10 2.17 0.98 .06 1.11
Anxiety Likert post Stroop 3.00 1.10 2.17 1.17 .04 1.10
AUQ pre 19.67 8.69 19.17 6.31 .89 0.06
AUQ post 26.83 10.13 17.00 5.06 .03 1.53
CIWA-ARb 2.83 2.04 1.50 1.38 .04 2.74
SBP 145.67 23.69 140.50 20.07 .61 0.22
DBP 93.33 16.03 89.17 10.67 .50 0.31
HR 81.33 24.46 77.83 8.45 .70 0.23
WTAR T 57.67 4.50 58.17 3.49 .62 0.24
Stroop Color T 41.50 8.02 43.50 9.01 .36 0.42
Stroop Word Tb 47.00 8.76 45.83 8.35 .60 0.31
Stroop Color-Word T 47.83 7.41 50.5 6.35 .14 0.73
Stroop interference T 48.83 7.47 50.83 4.92 .38 0.45

Note: Pre/post Stroop = during scan, just before/after multisensory Stroop task, AUQ = Alcohol Urge Questionnaire, CIWA = revised clinical institute withdrawal assessment for alcohol scale, SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, WTAR = Weschler Test of Adult Reading. T indicates t score used. All t tests (two-tailed, paired) performed in Microsoft Excel.

a

Derived from means, SD, and correlation between samples at http://cognitiveflexibility.org/effectsize/ using recommended approaches for within subjects effects [Morris, S. B., & DeShon, R. P. (2002). Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychological Methods, 7, 105–125.]

b

Non-parametric tests (Wilcoxon Signed Rank) performed when significance met (p < .05) on the Shapiro–Wilk test of normality in SPSS.